-
Je něco špatně v tomto záznamu ?
Evidence of necroptosis in hearts subjected to various forms of ischemic insults
A. Adameova, J. Hrdlicka, A. Szobi, V. Farkasova, K. Kopaskova, M. Murarikova, J. Neckar, F. Kolar, T. Ravingerova, NS. Dhalla,
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV15-27735A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Medline Complete (EBSCOhost)
od 2001-01-01 do Před 1 rokem
PubMed
28472590
DOI
10.1139/cjpp-2016-0609
Knihovny.cz E-zdroje
- MeSH
- apoptóza * účinky léků MeSH
- ischemická choroba srdeční metabolismus patologie MeSH
- komplex proteinů jaderného póru metabolismus MeSH
- lidé MeSH
- myokard metabolismus patologie MeSH
- nekróza MeSH
- proteinkinasy metabolismus MeSH
- proteiny vázající RNA metabolismus MeSH
- serin-threoninkinasy interagující s receptory metabolismus MeSH
- signální transdukce MeSH
- TNF-alfa metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Long-lasting ischemia can result in cell loss; however, repeated episodes of brief ischemia increase the resistance of the heart against deleterious effects of subsequent prolonged ischemic insult and promote cell survival. Traditionally, it is believed that the supply of blood to the ischemic heart is associated with release of cytokines, activation of inflammatory response, and induction of necrotic cell death. In the past few years, this paradigm of passive necrosis as an uncontrolled cell death has been re-examined and the existence of a strictly regulated form of necrotic cell death, necroptosis, has been documented. This controlled cell death modality, resembling all morphological features of necrosis, has been investigated in different types of ischemia-associated heart injuries. The process of necroptosis has been found to be dependent on the activation of RIP1-RIP3-MLKL axis, which induces changes leading to the rupture of cell membrane. This pathway is activated by TNF-α, which has also been implicated in the cardioprotective signaling pathway of ischemic preconditioning. Thus, this review is intended to describe the TNF-α-mediated signaling leading to either cell survival or necroptotic cell death. In addition, some experimental data suggesting a link between heart dysfunction and the cellular loss due to necroptosis are discussed in various conditions of myocardial ischemia.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010598
- 003
- CZ-PrNML
- 005
- 20180417093709.0
- 007
- ta
- 008
- 180404s2017 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1139/cjpp-2016-0609 $2 doi
- 035 __
- $a (PubMed)28472590
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Adameova, Adriana $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
- 245 10
- $a Evidence of necroptosis in hearts subjected to various forms of ischemic insults / $c A. Adameova, J. Hrdlicka, A. Szobi, V. Farkasova, K. Kopaskova, M. Murarikova, J. Neckar, F. Kolar, T. Ravingerova, NS. Dhalla,
- 520 9_
- $a Long-lasting ischemia can result in cell loss; however, repeated episodes of brief ischemia increase the resistance of the heart against deleterious effects of subsequent prolonged ischemic insult and promote cell survival. Traditionally, it is believed that the supply of blood to the ischemic heart is associated with release of cytokines, activation of inflammatory response, and induction of necrotic cell death. In the past few years, this paradigm of passive necrosis as an uncontrolled cell death has been re-examined and the existence of a strictly regulated form of necrotic cell death, necroptosis, has been documented. This controlled cell death modality, resembling all morphological features of necrosis, has been investigated in different types of ischemia-associated heart injuries. The process of necroptosis has been found to be dependent on the activation of RIP1-RIP3-MLKL axis, which induces changes leading to the rupture of cell membrane. This pathway is activated by TNF-α, which has also been implicated in the cardioprotective signaling pathway of ischemic preconditioning. Thus, this review is intended to describe the TNF-α-mediated signaling leading to either cell survival or necroptotic cell death. In addition, some experimental data suggesting a link between heart dysfunction and the cellular loss due to necroptosis are discussed in various conditions of myocardial ischemia.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ischemická choroba srdeční $x metabolismus $x patologie $7 D017202
- 650 _2
- $a myokard $x metabolismus $x patologie $7 D009206
- 650 _2
- $a nekróza $7 D009336
- 650 _2
- $a komplex proteinů jaderného póru $x metabolismus $7 D028861
- 650 _2
- $a proteinkinasy $x metabolismus $7 D011494
- 650 _2
- $a proteiny vázající RNA $x metabolismus $7 D016601
- 650 _2
- $a serin-threoninkinasy interagující s receptory $x metabolismus $7 D053422
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a TNF-alfa $x metabolismus $7 D014409
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Hrdlicka, Jaroslav $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Szobi, Adrian $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
- 700 1_
- $a Farkasova, Veronika $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
- 700 1_
- $a Kopaskova, Katarina $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
- 700 1_
- $a Murarikova, Martina $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
- 700 1_
- $a Neckar, Jan $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Kolar, Frantisek $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Ravingerova, Tatiana $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
- 700 1_
- $a Dhalla, Naranjan S $u d Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
- 773 0_
- $w MED00001020 $t Canadian journal of physiology and pharmacology $x 1205-7541 $g Roč. 95, č. 10 (2017), s. 1163-1169
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28472590 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180417093807 $b ABA008
- 999 __
- $a ok $b bmc $g 1288083 $s 1007410
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 95 $c 10 $d 1163-1169 $e 20170504 $i 1205-7541 $m Canadian journal of physiology and pharmacology $n Can J Physiol Pharmacol $x MED00001020
- GRA __
- $a NV15-27735A $p MZ0
- LZP __
- $a Pubmed-20180404